Plain-English translation of NCT05590949 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Breast Cancer research guide โThis study is watching what happens to your bones after you stop taking denosumab (a bone-protective injection) and aromatase inhibitors (hormone-blocking pills used for breast cancer). Researchers want to understand whether bones become weaker after these medications are stopped, and whether some women are at higher risk of fractures. Your participation will help doctors better support breast cancer survivors.
When women stop taking these medications, their bones can sometimes weaken more quickly than expected. Doctors want to learn how often this happens, who is most at risk, and how to better protect bone health in breast cancer survivors after treatment ends.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will visit the clinic 5 times over 24 months. At each visit, your doctor will do a health assessment, take blood tests, and possibly order bone imaging scans to track your bone health. The study simply observes and measures what happens to your bones after stopping treatment โ you won't receive any new medication or procedures as part of this study.
AI-generated summary from trial data ยท Sep 3, 2026 ยท Not medical advice
United States